DelveInsight’s Helicobacter pylori Infection Market Insights report includes a comprehensive understanding of current treatment practices, Helicobacter pylori infection emerging drugs, market share of individual therapies, and current and forecasted market size from 2019 to 2032, segmented into 7MM…
The Global Prothrombin Complex Concentrates Market Size was valued at USD 771.2 billion in 2021 and the global prothrombin complex concentrates market...
The Illinois Biotechnology Innovation Organization (iBIO), the trade association that represents the 88,000 jobs in Illinois’ life sciences sector, today announced the addition of three new members to its board of directors: Rahul Jerath, senior director, head of Oncology Business Development & Acqu…
NEW YORK, Oct. 18, 2022 /PRNewswire/ -- The primary immunodeficiency therapeutics market is expected to grow by USD 3.13 billion during 2021-2026 according to the latest market research report by
JCMR recently announced Tumor Lysis Syndrome market survey which covers overall in-depth stud
The Non-Hodgkin Lymphoma Therapeutics Market Report (2022-2030) provides insightful data on business strategies, top industry trends, growth
The global sleep aid supplement market is estimated to grow with a moderate CAGR during the forecast period, i.e., 2021-2029.
Abstract: What`s New for 2022? Global competitiveness and key competitor percentage market shares. ...
<p>The planned all-stock transaction will enable Enliven to take over Imara’s Nasdaq listing with cash runway into 2026. Imara shareholders get contingent value rights tied to sold-off top candidate tovinontrine.</p>
Antifibrinolytics are one of the most commonly used drugs to prevent fibrinolysis by blocking the activation of plasminogen proenzyme and plasmin.
The Global Type 2 Diabetes Drugs Market size was estimated at USD 60. 82 billion in 2021 and expected to reach USD 65. 75 billion in 2022, and is projected to grow at a CAGR 8. 38% to reach USD 98.New York, Oct. 14, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report “Type…
...
<p>The Switzerland-headquartered group believes it has a potentially best-in-class GLP-2 agonist on its hands with apraglutide, which has proved effective in a subgroup of patients that do not benefit from standard of care Gattex.</p> <br class=“t-last-br” /> <br class=“t-last-br” />
The Global Women’s Health Therapeutics Market size was estimated at USD 53. 99 billion in 2021 and expected to reach USD 59. 43 billion in 2022, and is projected to grow at a CAGR 10. 32% to reach USD 97.New York, Oct. 14, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report…
Advisors to the European Medicines Agency on Friday backed the use of a tetravalent dengue vaccine by the German unit of Japan’s Takeda for people aged four years and above. ... | October 14, 2022
Rise in government support for research and development activities and surge in healthcare expenditure drive the growth of the global stem cell therapy...
Cancer Nanotherapy market Research Reports, Growth, Opportunities and Analysis by Top Leaders Forecast To 2029
R. Brent Wisner has been named to the Daily Journal’s Top 100 Lawyers list for the third time in his career.
Chronic Myeloid Leukemia Treatment Market Size to Surpass $10,864.9 Million, Booming at a CAGR of 6.0% by 2028 | F. Hoffmann-La Roche Ltd., Novartis AG, Bristol-Myers Squibb Company, Pfizer Medgadget
Ligand Pharmaceuticals Incorporated today announced that on October 3, 2022, the Human Capital Management and Compensation Committee of Ligand’s Board of Directors granted non-qualified... | October 4, 2022